Receives USFDA approval - Marksans Pharma Ltd

Code BSE: 524404 NSE:

Marksans Pharma Limited hereby announces the final approval of the Company’s wholly owned subsidiary Marksans Pharma Inc.’s Abbreviated New Drug Application for Loperamide Hydrochloride Tablets USP, 2 mg , This product is bioequivalent to the reference listed drug (RLD), Imodium A-D Tablets, 2mg, of Kenvue Brands LLC NDA - 019860. Loperamide Hydrochloride is an anti-diarrheal medication used to control symptoms of acute and chronic diarrhea.